Last updated: 2026-10-08 00:30:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
ClearPoint Neuro, Inc. (CLPT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $10,65, with a market capitalization of $351,41M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8,27 to $30,10. This page covers its latest market performance, valuation, price trends and company information.
$351,41M | |
$10,85 | |
$31,29 | |
$2,86 | |
$11,01 | |
438,20K | |
639,95K | |
-- | |
$30,10 | |
$8,27 | |
-- | |
-- |
ClearPoint Neuro, Inc. (CLPT) last closed at $11,01 as of 2026-10-07 23:31:00, unchanged from the previous close of $11,01.
During the latest regular trading session, CLPT traded between $2,86 and $31,29, with a volume of 438,20K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, ClearPoint Neuro, Inc. (CLPT) moved from $15,31 to $10,65, representing a decline of 30,46% ($4,66).
The stock traded between $10,58 and $15,42 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1,10 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 10,9%
CLPT is currently trading at $10,65, placing it 10,9% of the way from its 52-week low of $8,27 to its 52-week high of $30,10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 172 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ClearPoint Neuro, Inc. (CLPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.